Clinical Trial Update: Hybrid Persistent Atrial Fibrillation Ablation in Heart Failure [NA]

View source ↗

Summary

A clinical trial update indicates that the hybrid persistent atrial fibrillation ablation trial in heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Snippet

Sponsor: The Cleveland Clinic | Conditions: Atrial Fibrillation, Heart Failure | NA | Status: WITHDRAWN